Marie-France Savard

机构：University of Ottawa, Ottawa Hospital, Ottawa Hospital Research Institute · ORCID：0000-0002-7651-0870

发表论文 55 篇 · 总被引 363 次 · h-index 10

代表论文

• Zanidatamab plus palbociclib and fulvestrant in previously treated patients with hormone receptor-positive, HER2-positive metastatic breast cancer: primary results from a two-part, multicentre, single-arm, phase 2a study (2025 · The Lancet Oncology · 被引 16)
• Augmenting Insufficiently Accruing Oncology Clinical Trials Using Generative Models: Validation Study (2025 · Journal of Medical Internet Research · 被引 13)
• HER2CLIMB-05: A Phase III Study of Tucatinib Versus Placebo in Combination With Trastuzumab and Pertuzumab as First-Line Maintenance Therapy for HER2+ Metastatic Breast Cancer (2025 · Journal of Clinical Oncology · 被引 10)
• Improving Care for Older Adults with Cancer in Canada: A Call to Action (2024 · Current Oncology · 被引 10)
• A pragmatic, multicenter, randomized trial comparing morning versus evening dosing of adjuvant endocrine therapy (REaCT-CHRONO Study) (2025 · npj Breast Cancer · 被引 6)
• Abstract LBO1-04: Primary results from a phase 2a study of zanidatamab (zani) + palbociclib (palbo) + fulvestrant (fulv) in HER2+/HR+ metastatic breast cancer (mBC) (2024 · Cancer Research · 被引 5)